Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.

Acknowledgment of Support

This activity is supported by educational grant from Biogen and Jazz Pharmaceuticals, Inc

Community Practice Connections™: 2nd Annual International Congress on the Future of Neurology®

Release Date: November 24, 2020
Expiration Date: November 24, 2021

Activity Overview

This Community Practice Connections™ program provides an in-depth review of some of the key highlights from the 2nd Annual International Congress on the Future of Neurology®, held in September 2020. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with neurologic conditions including epilepsy, migraine, movement disorders, multiple sclerosis, sleep disorders, and stroke, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Acknowledgement of Commercial Support

This activity is supported by educational grant from Biogen and Jazz Pharmaceuticals, Inc

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This activity is directed toward physicians who treat patients with neurologic disorders. Fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals interested in the management of patients with neurologic disorders are also invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Describe strategies for the diagnosis and management of neurologic disorders
  • Discuss current standards of care and recent advancements for the treatment and prevention of neurologic disorders
  • Summarize the mechanism of action of therapeutic agents used to manage neurologic disorders
  • Recognize and mitigate adverse events of neurologic therapy
  • Apply multidisciplinary care strategies for optimizing patient outcomes in the setting of neurologic disorders
  • Evaluate emerging clinical trial data of investigational therapy for neurologic disorders

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Richard S. Bedlack, Jr., MD, PhD
Richard S. Bedlack, Jr., MD, PhD
Professor of Neurology
Director, ALS Clinic
Duke University
Durham, NC

Disclosures: Grant Research Support: ALSA, Orion; Consultant: ALSA, Alexion, Amylyx, Biogen, Brainstorm Cell, ITF Pharma, Mallinckrodt, New Biotic, Woolsey Pharmaceuticals

Karl Doghramji, MD
Karl Doghramji, MD
Professor of Psychiatry, Neurology, and Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Medical Director, Jefferson Sleep Disorders Center
Program Director, Fellowship in Sleep Medicine
Thomas Jefferson University Hospital
Philadelphia, PA

Disclosures: Grant Research Support: Harmony, Inspire, Eisai; Consultant: Harmony, Eisai, Merck & Co., Inc., Jazz, Teva, Pfizer; Shareholder: Merck & Co., Inc.

Richard S. Isaacson, MD
Richard S. Isaacson, MD
Director, Alzheimer’s Prevention Clinic
Weill Cornell Memory Disorders Program
Assistant Dean of Faculty Development
Weill Cornell Medicine and NewYork-Presbyterian Hospital
New York, NY

Disclosures: Richard S. Isaacson, MD has no relevant financial relationships with commercial interests to disclose.

Fred D. Lublin, MD
Fred D. Lublin, MD
Saunders Family Professor of Neurology
Director, The Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Icahn School of Medicine at Mount Sinai
New York, NY

Disclosures: Grant Research Support: Novartis, Actelion, Biogen, Sanofi, NMSS, NIH, Brainstorm Cell Therapeutics; Consultant: Biogen, EMD Serono, Novartis, Teva, Actelion/Janssen, Sanofi/Genzyme, Acorda, Roche/Genentech, MedImmune/ Viela Bio, Receptos/Celgene, TG Therapeutics, MedDay, Atara Biotherapeutics, Polpharma, Mapi Pharma, Innate Immunotherapeutics, Apitope, Orion Biotechnology, Brainstorm Cell Therapeutics, Jazz Pharmaceuticals; GW Pharma, Mylan, Immunic, Population Council, Avotres; Other: Sanofi (Nonpromotional)

Jeffrey B. Ratliff, MD
Jeffrey B. Ratliff, MD
Clinical Assistant Professor of Neurology
Director, Neurology Residency Program and Movement Disorders
Thomas Jefferson University
Philadelphia, PA

Disclosures: Grant Research Support: Acadia; Consultant: Teva, US World Meds/Supernus

Fred Rincon, MD, MSc, MB. Ethics, FACP, FCCP, FCCM
Fred Rincon, MD, MSc, MB. Ethics, FACP, FCCP, FCCM
Division Head, Cerebrovascular Disease – Farber Institute for Neuroscience
Associate Professor of Neurology and Neurological Surgery
Sidney Kimmel Medical College at Thomas Jefferson University
Department of Neurological Surgery
Division of Critical Care and Neurotrauma
Philadelphia, PA

Disclosures: Consultant: Bard; Speakers Bureau: Portola Pharmaceuticals; Other: NeuroCrit LLC, Founder

Stephen Silberstein, MD
Stephen Silberstein, MD
Professor of Neurology
Jefferson Headache Center
Philadelphia, PA

Disclosures: Consultant: AbbVie, Amgen, AEON BioPharma, Axsome Therapeutics, Biohaven Pharmaceuticals, Cefaly, Curelator, Epalex, GlaxoSmithKline Consumer Healthcare Holdings, electroCore, Impel NeuroPharma, Eli Lilly, Lundbeck, Nocera, Novartis, Revance: Saliva, BioElectronics, Satsuma Pharmacueticals, Supernus Pharmaceuticals, Teva, Theranica, Thermaquil, Trillium Medical Michael

Elizabeth A. Thiele, MD, PhD
Elizabeth A. Thiele, MD, PhD
Director, Pediatric Epilepsy Program
Director, Herscot Center for Tuberous Sclerosis Complex
Massachusetts General Hospital
Professor of Neurology
Harvard Medical School
Boston, MA

Disclosures: Grant Research Support: GW Pharma/Greenwich Biosciences, Zogenix; Consultant: GW Pharma/Greenwich Biosciences, Zogenix, Aquestive, Biocodex, Eisai, West Therapeutics, RegeneRx Bio, Nobelpharma

William B. Young, MD, FAHS, FAAN, FANA
William B. Young, MD, FAHS, FAAN, FANA
Professor of Neurology
Sidney Kimmel Medical College at Thomas Jefferson University
Jefferson Health
Philadelphia, PA

Disclosures: Disclosures: Grant Research Support: Amgen, Autonomic Technologies, Cumberland, Eli Lilly, Novartis, PCORI, Scion, Teva, Zosano; Consultant: Allergan, Amgen, Biohaven, Eli Lilly, Theranica; Speakers Bureau: Amgen, Eli Lilly, Teva

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By